Каждый путешественник должен позаботиться о себе и близких, собрав в дорогу медицинскую аптечку. По рекомендациям терапевтов, она должна содержать: средства от простуды и ОРВИ, препараты при отравлении и расстройстве ЖКТ, средства от травм и ран, антигистаминные препараты и солнцезащитные кремы.
Южнокорейская компания Samsung Electronics объявила о приобретению американской платформы Xealth, предоставляющую цифровые услуги в сфере здравоохранения.
Компания из Швейцарии Novartis получила одобрения на препарат Coartem Baby, который стал первым препаратом для лечения малярии у младенцев и детей младшего возраста.
В сложные периоды нашей жизни организм жаждет легкодоступной энергии. Мы часто обращаемся к нездоровой пище. Диетологи советуют, как справляться со стрессом с помощью питания.
ЗАДАТЬ ВОПРОС РЕДАКТОРУ РАЗДЕЛА (ответ в течение нескольких дней)
19 июня 2002 00:00
Coronary hybrid revascularization from January 1997 to January 2001: a clinical follow-up
Background. Hybrid revascularization (HyR), combining minimallyinvasive left internal mammary artery (LIMA) bypass graftingto the left anterior descending coronary artery (LAD) and catheterinterventional treatment of the remaining coronary lesions,avoids the disadvantages associated with cardiopulmonary bypass(CPB). We investigated the clinical follow-up of 57 patientswith multivessel disease undergoing this procedure in the last4 years.
Methods. Between January 1997 and January 2001, 57 consecutivepatients (41 men and 16 women, aged 65.7 ± 7.9 years)with coronary artery disease (two-vessel, n = 34; three-vessel,n = 23) were treated with off-pumpLIMA-to-LAD bypass combinedwith balloon angioplasty and stenting of the remaining significantlyobstructed (> 50%) coronary vessels. Clinical follow-up dataincluded a early postoperative and a 6−month control angiographyand a patient interview in January 2001.
Results. All patients underwent LIMA-to-LADbypass-graftingand balloon angioplasty in 72 coronary lesions without procedural-relatedcomplications. However, one early LIMA bypass occlusion wasdocumented during coronary angiography. Postoperatively no deteriorationof preexistent organ dysfunction was observed in any patient.The mean follow-up was 100.7 ± 37.9 weeks in 55 of 57patients (97%). Control angiography 6 months after HyR (n =34) revealed a patent LIMA bypass in 33 patients and 8 in-stentrestenoses (> 50%) in the coronary arteries that were treatedinterventionally by re-PTCA (n = 6) or by conventional CABG(n = 1). In 1 patient medical treatment resulted in significantreduction of angina so no further intervention was considerednecessary. After HyR 1 patient died 18 months later of an intracerebralhemorrhage. All other patients are alive and doing well.
Conclusions. Our results indicate that in selected patientswith multivessel disease including left main stem stenosis HyRis an effective and secure procedure with excellent early andgood midterm results. Especially elderly patients with severeconcomitant diseases appear to benefit from this approach byavoiding CPB.
Background. Despite increasing clinical use and recent evidence that insulin-like growth factor-1 (IGF-1), insulin-like growth factor binding protein-3 (IGFBP-3), and human growth hormone (hGH)
Background. Statins may enhance vascular function independently of effects on cholesterol. This study investigated the ability of statins to modulate the vascular recovery of arteries
Background. The gastroepiploic artery (GEA) has been used as a graft in 1,000 patients in our institution, and the clinical outcome and the angiographic long-term results were reviewed.
Methods.
Background. In studies of gender effects on outcome after coronary artery bypass grafting, early mortality has consistently tended to be higher among women, whereas long-term results have varied.
Background. The impact of aortic manipulation on incidence of cerebrovascular accidents (CVAs) was evaluated in patients who underwent myocardial revascularization.
Methods. From January 1988